Company profile for Crestone

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Crestone, Inc. is a drug discovery and development company focused on developing novel treatments for serious bacterial infections. The company currently has two programs that address areas of significant and growing unmet medical need, both with novel mechanism of action agents. 1. Novel antibiotic for Clostridium difficile infections. CRS3123 (formerly known as REP3123) is in development fo...
Crestone, Inc. is a drug discovery and development company focused on developing novel treatments for serious bacterial infections. The company currently has two programs that address areas of significant and growing unmet medical need, both with novel mechanism of action agents. 1. Novel antibiotic for Clostridium difficile infections. CRS3123 (formerly known as REP3123) is in development for the treatment of C. difficile infection (CDI).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6075 Longbow
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240904819996/en

BUSINESSWIRE
05 Sep 2024

https://www.fiercebiotech.com/biotech/crestones-new-antibiotic-cures-c-diff-infections-and-prevents-recurrence-better-vancomysin

FIERCE BIOTECH
05 Sep 2024

https://www.prnewswire.com/news-releases/crestone-inc-and-praedicare-inc-announce-the-publication-of-data-on-the-novel-antibiotic-crs0540-in-the-hollow-fiber-system-model-of-the-orphan-disease-disseminated-listeriosis-301606053.html

PRNEWSWIRE
15 Aug 2022

https://www.prnewswire.com/news-releases/crestone-joins-antimicrobials-working-group-301308125.html

PRNEWSWIRE
08 Jun 2021

https://www.biospace.com/article/releases/crestone-inc-enrolls-first-patient-in-phase-2-clinical-trial-for-novel-antibiotic-crs3123-to-treat-c-difficile-infections/

BIOSPACE
07 Jun 2021

https://www.businesswire.com/news/home/20200701005065/en

BUSINESSWIRE
30 Jun 2020

ABOUT THIS PAGE

Contact Crestone and get a quotation

Crestone is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of CRS3123 bulk with DMF offered by Crestone

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty